Tech Company Acquirers
ImmunogenX
Looking for who was acquired by ImmunogenX? Alvine Pharmaceuticals did a deal with this ambitious biopharmaceutical company.
Company Overview
Company Name
ImmunogenX
Company Status
Private & Independent
Industry
Biopharmaceutical
Acquisitions
Contact Information
Mailing Address
1600 Dove St. 330
Newport Beach, CA 92660
USA
Newport Beach, CA 92660
USA
Phone
Website
Email Address
Company Background Information
Overview
ImmunogenX (a subsidiary of Immunogenics LLC) is a clinical-stage company founded in 2013 and is supported by a team of world-renowned clinicians, scientists and advisors in celiac disease research. In addition to the newly-acquired IMGX-003, ImmunogenX is developing an advanced diagnostic tool.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/16/2016
Acquisitions By ImmunogenX
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jack Syage
Chief Operating Officer
Matthew Dickason
VP - Sales
Jennifer Sealey-Voyksner
Browse more tech company acquirers:
imeem | ImmunoVaccine Technologies
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs